Share
Share today's newsletter with a colleague and get credit if they sign up for SmartBrief.
Referral Count:
 
0

Story being shared
Biomaterials supplier strikes stem cell deal with ReNeuron
Angel Biotechnology has entered into an agreement to aid the stem cell work of ReNeuron. ReNeuron is advancing studies of stem cell treatments for stroke. "This contract will ensure the provision of further drug substance material required to service our ongoing therapeutic programs," ReNeuron CEO Michael Hunt said.

Or we can send an email on your behalf
You must submit valid email addresses only. Use of email addresses is subject to terms of SmartBrief's privacy policy .